Cargando…
Imaging of carbonic anhydrase IX with an (111)In-labeled dual-motif inhibitor
We developed a new scaffold for radionuclide-based imaging and therapy of clear cell renal cell carcinoma (ccRCC) targeting carbonic anhydrase IX (CAIX). Compound XYIMSR-01, a DOTA-conjugated, bivalent, low-molecular-weight ligand, has two moieties that target two separate sites on CAIX, imparting h...
Autores principales: | Yang, Xing, Minn, Il, Rowe, Steven P., Banerjee, Sangeeta Ray, Gorin, Michael A., Brummet, Mary, Lee, Hye Soo, Koo, Soo Min, Sysa-Shah, Polina, Mease, Ronnie C., Nimmagadda, Sridhar, Allaf, Mohamad E., Pomper, Martin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741798/ https://www.ncbi.nlm.nih.gov/pubmed/26418876 |
Ejemplares similares
-
[(64)Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
por: Minn, Il, et al.
Publicado: (2016) -
A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents
por: Chen, Ying, et al.
Publicado: (2022) -
(64)Cu-Labeled Inhibitors
of Prostate-Specific
Membrane Antigen for PET Imaging of Prostate Cancer
por: Banerjee, Sangeeta Ray, et al.
Publicado: (2014) -
Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer
por: Shen, Colette J., et al.
Publicado: (2020) -
Heterobivalent Agents Targeting PSMA and Integrin-α(v)β(3)
por: Shallal, Hassan M., et al.
Publicado: (2014)